Business · National
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Verified Timeline
No verified timeline updates.
What is your view on “Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval”?
This is self-selected reader participation, not representative scientific polling.

